Tango Therapeutics (TNGX) Current Assets (2020 - 2026)

Tango Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $392.3 million for Q1 2026.

• In Q1 2026, Current Assets rose 74.42% year-over-year to $392.3 million; the TTM figure through Mar 2026 stood at $392.3 million (up 74.42% YoY), while the FY2025 annual figure was $353.8 million, up 32.82% from the prior year.
• Current Assets was $392.3 million for Q1 2026 at Tango Therapeutics, up from $353.8 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $460.7 million in Q1 2022 to a low of $163.8 million in Q3 2025.
• Historically, Current Assets has averaged $331.0 million across 5 years, with a median of $346.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Assets surged 59288.42% in 2022, then slumped 45.55% in 2025.
• A 5-year view of Current Assets shows it stood at $375.3 million in 2022, then fell by 7.66% to $346.5 million in 2023, then dropped by 23.14% to $266.3 million in 2024, then surged by 32.82% to $353.8 million in 2025, then advanced by 10.9% to $392.3 million in 2026.
• The last three Current Assets figures came in at $392.3 million (Q1 2026), $353.8 million (Q4 2025), and $163.8 million (Q3 2025), per Business Quant data.